What causes a left temporal lobar bleed, particularly in older adults with hypertension or on anticoagulant therapy?

Causes of Left Temporal Lobar Intracerebral Hemorrhage

In older adults, left temporal lobar hemorrhage is most commonly caused by cerebral amyloid angiopathy (CAA) in non-hypertensive patients and hypertensive arteriopathy in hypertensive patients, with anticoagulant therapy dramatically increasing risk regardless of underlying etiology. 1, 2

Primary Etiologies by Patient Profile

Non-Hypertensive Elderly Patients (Most Common Scenario)

• Cerebral amyloid angiopathy is the leading cause of lobar hemorrhage in elderly non-hypertensive patients, characterized by amyloid deposition in cortical and leptomeningeal vessel walls 2, 3
• CAA should be strongly suspected when lobar hemorrhage occurs in patients >70 years without hypertension history 1
• MRI findings supporting CAA include multiple lobar microbleeds, cortical superficial siderosis, and white matter changes in the absence of deep hemorrhage patterns 3

Hypertensive Patients

• Hypertension remains a major cause even in lobar locations, present in 67% of lobar hemorrhage cases across all age groups 4
• Contrary to older assumptions, hypertension frequency in lobar hemorrhage does not diminish with advancing age 4
• However, hypertension is slightly less common in lobar (67%) compared to deep (73%), cerebellar (73%), or pontine (78%) hemorrhages 4

Anticoagulation-Related Hemorrhage

Warfarin-Associated Bleeding

• Anticoagulation increases intracerebral hemorrhage risk 7-10 fold, to an absolute rate of nearly 1% per year in stroke-prone patients 5
• Approximately 70% of anticoagulant-related intracranial hemorrhages are intracerebral hematomas, with 60% mortality 5
• Critical feature: bleeding evolves slowly over 12-24 hours in approximately half of anticoagulated patients, making emergency reversal crucial 5, 6
• Risk factors include advanced age, prior ischemic stroke, hypertension, and intensity of anticoagulation 5

Management of Anticoagulant-Related Hemorrhage

• Immediately discontinue warfarin and administer 4-factor PCC (25-50 IU/kg based on INR) without waiting for INR results 7, 6
• Always give IV vitamin K (5-10 mg) alongside PCC to prevent INR rebound, targeting INR <1.5 7, 6
• For patients on direct oral anticoagulants, use idarucizumab for dabigatran reversal or andexanet alpha (or 4F-PCC if unavailable) for factor Xa inhibitor reversal 7

Structural Vascular Abnormalities

When to Suspect Secondary Causes

• Subarachnoid extension of hematoma on CT strongly indicates non-hypertensive cause and specifically suggests vascular abnormalities 8
• Vascular workup is recommended for: age <70 years with lobar ICH, age <55 years regardless of location, absence of hypertension history, or presence of subarachnoid blood 1

Specific Structural Lesions

• Arteriovenous malformations, aneurysms, dural arteriovenous fistulas, and tumors (particularly metastases) 1
• CTA is highly sensitive and specific for detecting vascular abnormalities and should be performed in younger patients or those with atypical features 1
• Catheter angiography may be considered if clinical suspicion is high or non-invasive studies are suggestive 1

Less Common Causes

Coagulopathies and Medications

• Antiplatelet agents (aspirin, clopidogrel) increase hemorrhage risk, though less dramatically than anticoagulants 2
• Hematologic disorders including thrombocytopenia and coagulation factor deficiencies 2
• Liver cirrhosis with associated coagulopathy 8

Other Etiologies

• Cerebral venous thrombosis (consider if edema is disproportionate to hemorrhage size or unusual location) 1
• Sympathomimetic drugs (cocaine, amphetamines) particularly in younger patients 2, 1
• Moyamoya disease 1

Critical Diagnostic Algorithm

For any left temporal lobar hemorrhage, systematically evaluate:

1. Age and hypertension status: If >70 years and non-hypertensive, CAA is most likely; if hypertensive at any age, consider hypertensive arteriopathy 2, 4

2. Anticoagulation/antiplatelet use: Check INR, platelet count, and medication history immediately 2, 5

3. CT findings: Look for subarachnoid extension (suggests vascular abnormality), unusual hematoma shape, or disproportionate edema 1, 8

4. Vascular imaging: Perform CTA in patients <70 years, non-hypertensive patients, or those with subarachnoid extension 7, 1

5. MRI when stable: Identify microbleeds (CAA), cortical superficial siderosis (CAA), or underlying masses 1, 3

Common Pitfalls to Avoid

• Do not assume all lobar hemorrhages in elderly patients are due to CAA—hypertension remains important across all ages 4
• Do not delay anticoagulation reversal while waiting for confirmatory INR results in suspected warfarin-related hemorrhage 6
• Do not skip vascular imaging in younger patients (<55-70 years) even with hypertension, as structural lesions are more common 1
• Do not restart anticoagulation in CAA patients—permanent avoidance is recommended due to extremely high recurrence risk 3